Week 1 Pharmacodynamics and pharmacokinetic Flashcards

1
Q

Pharmacodynamics

A

Pharmacodynamics
Defined as “ The actions of a drug on the body”
“What does the drug do to the body? ”
Describes a drug’s molecular, biochemical, and physiologic effects or actions occurring by binding to specialized target macromolecules (receptors) on or in the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug-receptor complex

A

Starts biological molecular activities by signal transduction
Magnitude of cellular response: proportional to the number of drug-receptor complex
More drug binding to receptor more physiological receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transmembrane ligand-gated(subtance/drug-gated) Ion Channels

A

Regulates cellular access of soluble ions (Na++, K+)

Ligand-binding area is on the cell membrane

Key feature: downregulation of receptors

Receptors may be internalized within the cell, making them unavailable for further agonist interaction ability to hide within the cell, leading to no more binding in the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

G-Protein-Coupled Receptors

A

Generate intracellular second messengers to initiate cellular cascade for intracellular effect.

Has ability to amplify signal intensity and duration

Example: Alpha- and beta- adrenergic receptors; hormone receptors

When hormone or drug bind the receptor, it changes the receptor shape, leading it to interaction to G protein (GTP to GDP), alpha and other attaches itself to acti adenyly cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enzyme-linked Receptor(insulin receptor or growth factor receptor)

A

Increase intracellular enzyme activity (tyrosine kinase) -> ^ autophosphorylation
Last for minutes to hrs
Has ability to amplify signal intensity and duration
Ex: Growth factor and insulin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intracellular receptors

A

Cytoplasmic receptors,
Respond to lipid soluble ligand molecules
Drug attaches to receptor -> Moves into nucleus -> initiates DNA transcription -> mRNA -> specific proteins -> biologic effects
The effect of drugs or endogenous ligands that activate intracellular receptors takes hours to days to occur.
Ex: steroid and thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initial small signal gets amplified in the signal pathways (Signal Cascade Effect)

A

Need only a fraction of the total receptors for a specific ligand to be occupied to elicit a maximal response.

Some receptors are “spare”
About 99% of insulin receptors are “spare,”

Provides an immense functional reserve that ensures that adequate amounts of glucose enter the cell.
Only about 5% to 10% of the total β-adrenoceptors in the heart are spare.
Little functional reserve exists in the failing heart, because most receptors must be occupied to obtain maximum contractility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Down regulation

A

Reduced synthesis of new receptors

Usually happens with repeated exposure to an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sequestration or Internalization

A

Sequestration or Internalization
Degradation of preexisting receptors through endocytosis
Usually happens with repeated exposure to agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Up-regulation of receptors

A

Receptor reserves are inserted into the membrane, increasing the number of receptors available.
Usually happens with repeated exposure of a receptor to an antagonist
Can make cells more sensitive to agonists and/or more resistant to effects of the antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Desensitization or Tachyphylaxis

A

A rapid decrease in response (effects of medication) to chronic, repeated exposure to agonist over a short time period , (Could occur at the initial dose)

Etiologies
Downregulation or sequestration of receptors
Exhaustion of secondary messengers
^ metabolic degradation of the medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tolerance

A

A slow decrease in response to chronic, repeated exposure to agonist
Seen in chronic opioid users: Target receptors are reduced -> higher dose is needed to have same benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potency

A

requires less amount to produce therapeutic effect

A measure of the amount of drug necessary to produce a given effect.
Indicated as half maximal effective concentration (EC50)
The concentration of drug producing 50% of the maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Efficacy

A

The magnitude of response when a drug interacts with a receptor
Dependent on the number of drug–receptor complexes and the intrinsic activity of the drug
The relative ability of agonist to fully or partially activate receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Maximal efficacy of a drug (Emax)

A

Occurs when the drug occupies all receptors (generally meds have a maximum dose because after taking a certain amount, it is found that no matter how much more you take will not increase the efficacy of the drug)

No increase in response to higher concentrations of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intrinsic activity of drugs

A

A measure of the ability of a drug in producing a change in cellular activity when it binds to the receptors
Determines its ability to fully or partially activate the receptors.
Drugs may be categorized according to their intrinsic activity and resulting Emax values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Affinity

A

A measure of the tightness with which a drug binds to the receptor
Higher affinity -> Higher potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ligands

A

: endogenous hormones or neurotransmitters (ex: adrenalines: norepinephrine, epinephrine)
Bind to the specific receptors that results in physiological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

synthetic ligands

A

Drugs: synthetic ligands (i.e thyroid meds, bind to thyroid sites)
Receptors:
Protein molecules
Located on the organs of our body ( inside the cell or on its membrane)
Bind to specific ligands: Causes physiological responses in our body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Full Agonists

A

Produce a maximal biologic response(Same Emax) that mimics the response to the endogenous ligand that is supposed to bind to the receptor

Eg:
Phenylephrine is a full agonist at α1-adrenoceptors
Produces the same Emax as the endogenous ligand, norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Partial Agonists

A

Cannot produce the same Emax as a full agonist even when all the receptors are occupied

May function as antagonist when given with full agonist

Compete for receptors with full agonist

Emax of a full agonist would decrease until it reached the Emax of the partial agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Competitive reversible Antagonist

A

Characteristic shift of the agonist dose–response curve to the right (increased EC50 ) without affecting Emax

Eg: Terazosin (compete with natural neurotransmitter , epinephrine at α1-adrenoceptors)

Requires more epinephrine given to get the same result when given with terazosin since terazosin also competes to binding site (competitive reversib le antagonist - but removable when have enough agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Competitive Irreversible Antagonist

A

Competes for the same sites of the receptors with agonist

Binding is not reversible
Permanently reduce the number of receptors available to the agonist

Causes a downward shift of the Emax, with no change EC50 values

Addition of more agonist does not overcome the effect of irreversible antagonists.

Competitive irreversible antagonist will not come off of the recetpro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Allosteric (Noncompetitive) antagonist

A

Binds to a site (allosteric site) other than the agonist-binding site and prevents receptor activation by agonist

Irreversible binding
Causes a downward shift of the Emax of an agonist, with no change in the EC50 value.

Competitive reversible antagonists reduce agonist potency (increase EC50)

Competitive irreversible antagonist and noncompetitive antagonists (allosteric antagonist) reduce agonist efficacy (decrease Emax).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Effective Dose (ED 50)
Effective Dose (ED 50):the dose of a drug that produces, on average, a specified all-or-none response in 50% of a test population
26
Toxic Dose (TD50):t
Toxic Dose (TD50):the dose required to produce a particular toxic effect in 50% of a test population
27
Lethal Dose (LD 50):
Lethal Dose (LD 50): the dose required to kill 50% of a test subject population
28
Therapeutic Index
Therapeutic Index Determined using drug trials and accumulated clinical experience Reveal a range of effective doses and a different (sometimes overlapping) range of toxic doses High TI values are required for most drugs Some drugs with low therapeutic indices are routinely used to treat serious diseases When the risk of experiencing adverse effects is not as great as the risk of leaving the disease untreated
29
First pass effect
phenomenon of drug metabolism whereby the concentration of a drug, specifically when administered orally, is greatly reduced before it reaches the systemic circulation. It is the fraction of drug lost during the process of absorption which is generally related to the liver and gut wall
30
What is Pharmacokinetics?
What the body does to the drug? Absorption: how the drug gets into the body Distribution: where the drug goes to in the body Metabolism: how the body chemically modifies the drug Excretion: how the body gets rid of the drug
31
Absorption
Site: gut to plasma bio availability factors: drug characterisitcs, blood flow, cell membrane
32
Distribution
``` sites: plasma to tissue volume of distribution phases: 1) blood flow from site of adminstration 2) delivery of drug into tissues at site of drug actiob ```
33
Biotransformation (Metabolism)
Site: liver enzyme inhibition/induction first pass effect phase1: oxydation cytochrome P450 phase2: glucuronidation
34
Elimination
Site: kidney | clearance, halflife, steady state, linear/nonlinear kinetics
35
4 ways of Absorption from GI tract
Passive Transport: Passive diffusion, Facilitated diffusion Active Transport: requires energy Endocytosis: large molecule transport
36
Strong acid or base
``` Completely dissociate in water Completely polarized (Ionized or charged) in water ```
37
Weak acid or base
``` Partially dissociate in water Partially polarized (Ionized or charged)) in water ```
38
Passive diffusion
No energy expenditure by cell Movement through the concentration gradient: move from high concentration to low concentration Ficks Law: “The greater the distance and the larger the molecule, the slower the diffusion rate” Majority of drugs are absorbed by passive diffusion
39
Facilitated Diffusion
Movement through the concentration gradient Does not require energy Process that uses drug transporter protein Facilitate the passage of large molecules Drug transporters undergo conformational changes Allow the passage of drugs or endogenous molecules into inside of cells. Can be saturated May be inhibited by compounds that compete for the drug transporter (transporter in use, unable to transport others)
40
Active Transport
Protein molecules act as transporters across cell membrane Large molecules can enter the cells via this process Molecule from lower concentration to high concentration, uses ATP - energy to bring large molecules into high concentration area Selective permeability of cell membrane: Ability to differentiate between different types of molecules Requires energy expenditure
41
Absorption_Endocytosis
Used to transport drugs of exceptionally large molecular size Involves engulfment of a drug by the cell membrane and transport into the cell by pinching off the drug-filled vesicle. Vitamin B12 is transported across the gut wall by endocytosis
42
Factors Affecting Absorption
pH of the environment where drug is in Blood flow to the absorption site Expression of P-glycoprotein (Drug transporter molecules)\ Total surface area available for absorption Contact time at the absorption surface pH of the environment where drug is in Blood flow to the absorption site Expression of P-glycoprotein Total surface area available for absorption Contact time at the absorption surface
43
Pharmacokinetic vs Pharmacodynamics
Pharmacokinetic interactions ADME properties of the drug is altered by the precipitants Pharmacodynamic Interactions The activity of the object drugs at its side of action is altered by the precipitant
44
Distribution
Altered distribution pattern of the drug by affecting the protein-binding capacity of the drug (Object drug) Precipitant drug may displace the drug (Object drug) from it’s binding site Increases the amount of free, circulating drug May lead to toxicity Usually transient because free drug is subject to metabolism Clinically significant drug displacement interactions occur when: Drugs are > 90% protein bound and Narrow therapeutic index
45
Excretion
Acidification or alkalinization of urine Urine pH determines the ionization state of the excreted molecule Ionized molecules become trapped in urine and are excreted Weak acidic medication is combined with alkaline urine in kidney, like weak basic medication is combined with acidic urine in kidney, ionized molecule become trapped and unable to reutn back to the bloodstream/become reabsorbed
46
How does high fat food affect drug absorption?
Increase absoprption rate of lipophilic drugs
47
How does diary product affect drug absorption?
bioavalibility of tetracyclin and fluoroquinolone antibodies
48
How does orange, tomato, grapefruit juice: alkaline urine affect drug absorption?
bioavalibilty of weak base drugs P450 interaction with grapefruit juices
49
How does Rich in Vit K affect drug absorption?
opposte the anti coagulartory efficacy of warfarin
50
How does rich in tyramine affect drug absorption? | what food is rich in tyramine?
(aged cheese, dry type summer sausage, pepperoni, salami) precipitate a hypertensive crisis in patient with MAO inhibitors MAOI increase breakdown and absorption of tyramine
51
How does acacia- fiber suppliement affect drug absorption?
slows or reduce absoprtion of amoxicillin | doses should be separated by 4 hours
52
How does St. John's wort affect drugs?
induces CYP3A4, 2E1, 2C19 clinically signifi ant interaction with immunosupressant, hypoglucemics, anti inflammatory agents, antimicrobial agents, anti migraine medication, oral contraceptives, cardiovascular agents, antivirtals, CNS, GI, respiraotry agents,
53
GI transit time (GI Motility) delayed by
High fat meals Solid foods: The presence of food in the stomach both dilutes the drug and slows gastric emptying. Therefore, a drug taken with a meal is generally absorbed more slowly Diarrhea : Drug moves through the GI tract very fast. Lower absorption
54
Bioavailability:
The % of the drug that reaches the systemic circulation Depends upon the route of administration and ability to pass through membranes or barriers in the body IV = 100% bioavailability PO = Variable calculated based on AUC Area Under Curve(AUC):Represents the total exposure to a drug that the body receives.
55
First pass metabolism ( First pass effect)
A phenomenon in which a drug gets metabolized at a specific location in the body Results in a reduced concentration of the active drug upon reaching its site of action or the systemic circulation. Affects efficacy of the drug, may require higher dose? Often associated with the liver, as this is a major site of drug metabolism. Also occur in the lungs, vasculature, gastrointestinal tract, and other metabolically active tissues in the body Crucial to the proper administration and maintenance of pharmacological therapy.
56
Factors Affecting Bioavailability
First-Pass metabolism Solubility of the drugs Chemical instability transportation Nature of the drug formulation
57
For a drug to be readily absorbed, it needs to be what?
Very hydrophilic drugs: Poorly absorbed because of the inability to cross lipid-rich cell membranes. Extremely lipophilic drugs: Poorly absorbed, because they are insoluble in aqueous body fluids For a drug to be readily absorbed Must be largely lipophilic Yet have some solubility in aqueous solutions. This is one reason why many drugs are either weak acids or weak bases.
58
Expression of P-glycoprotein | Transmembrane drug transporter protein:
Function as efflux pump, pumping its substrates from inside to outside the cell. Affects the plasma and tissue concentrations of the drugs and ultimately the final effects. Known as multidrug resistance protein 1 (encoded by MDR1) High expression of this protein pump reduces absorption
59
Stomach and Duodenum have what kind of pH
acidic pH Weak acid drug with more non-ionization Become more nonionized when pH is decrease Better absorption Due to thick mucus in the stomach, poor absorption even if weak acid meds
60
Ileum's pH is
: Alkaline pH | Weak base drug becomes more nonionized
61
Absorption
: how the drug gets into the body
62
Distribution
: where the drug goes to in the body
63
Metabolism
: how the body chemically modifies the drug
64
Excretion
: how the body gets rid of the drug
65
What are the two phases of biotransformation and what do they do
Phase 1: Oxidation, hydrosis or reduction Drug changed to form a more polar or water-soluble compound Involves Cytochrome P450 (CYP) system Phase 2: Conjugation (Glucuronidation) Adds a conjugate (glucuronide and others) to the parent drug or phase 1 metabolized drug to increase water- solubility and enhance excretion.
66
What is Phase 1 of biotransformation in the liver?
Oxidation, hydrosis or reduction Drug changed to form a more polar or water-soluble compound Involves Cytochrome P450 (CYP) system
67
What is Phase 2 of biotransformation in the liver?
Conjugation (Glucuronidation) Adds a conjugate (glucuronide and others) to the parent drug or phase 1 metabolized drug to increase water- solubility and enhance excretion.
68
Cytochrome P 450 (CYP ) enzymes in Phase I
A protein superfamily of heme-containing isoenzymes located in most cells. Primarily in the liver and GI tract- where its converted into forms that can be excreted Considerable genetic variability Poor metabolizer vs rapid metabolizer May alter drug efficacy and the risk of side effects
69
What are the three types of P450 enzymes
substrate, inducer, or inhibitor
70
What is a substrate
Drugs utilize CYP enzymes for normal metabolization​ Drugs are metabolized by using the enzyme There may be some inducer to increase the process of the enzyme activity, but CYP2D6 doesnt have inducer
71
What is a Inducer?
- increase elimination of Drugs that stimulates the production of enzyme available to metabolize certain drugs​ Will increase metabolism​ of certain drugs Could result in less efficacy ​of certain drugs Ex: Rifampin (Inducer) for HIV protease inhibitor Enzyme induction and inhibition are the basis of metabolically-mediated drug-drug interactions If takes drugs that are inducers the drug that is taken will be excreted out faster It taken 2 drugs, a common substrate and a inducer, the dosage may need to be increased to provide the same effect
72
What is a Inhibitor
- slow down elimination of Drugs that inhibit the production of an enzyme and thereby decreases the metabolism of certain drugs.​ Will slow down elimination of certain drugs​ Could result in increased concentration of certain drugs Could result in adverse effects​ of certain drugs Ex: Omeprazole (Inhibitor) for Warfarin​
73
Polymorphism
​: The presence of genetic variances in single gene that result in the different phenotypes.
74
What is biotransformation?
(drug metabolism) - usually happens in liver, its elimination of drug Necessary steps for change of drugs into water-soluble forms to be easily excreted. Active form of drug to inactive form through metabolism to be excreted by kidney or in bile. The kidney cannot efficiently excrete lipophilic drugs - usually passes the cell membrane of kidneys very well leading to reabsoprtion in distal convulented tubules Waterphilic gets excreted faster Primarily occurs in the liver: Phase I and II Reaction
75
what is Pharmacogenomics
Relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) The study of how genes affect a person’s response to drugs To develop effective, safe medications and doses that will be tailored to a person’s genetic makeup
76
What are 3 factors that affects Distribution
Cardiac output/local blood flow to the area of action Capillary permeability- how well the medication can go through capillary tells ho far the medication can go through tissue Degree of binding of the drug to plasma proteins or tissue proteins
77
What are the 3 Plasma proteins:
Albumin, Globulin, Fibrinogen
78
What does Albumin do?
The most abundant / Made by the liver Transport vehicles for fatty acids and steroid hormones (Binding protein) Bind to various substances The most significant contributor to the osmotic pressure of blood Holds water inside blood vessle, and draw the volume from outside the wall into the wall
79
What does Globulin do?
The gamma globulins Involved in immunity Known as an antibodies or immunoglobulins. Alpha, beta globulins : Transport iron, lipids, and the fat-soluble vitamins A, D, E, and K to the cells Contribute to osmotic pressure
80
What is Fibrinogen?
Essential for blood clotting
81
What is Volume of Distribution (Vd)?
Be used to determine the size of a loading dose in order to quickly reach the required therapeutic plasma concentration - Hypothetical volume Defined as the fluid volume that is required to contain entire drug in the body at the same concentration measured in the plasma Reflects the extent to which the drug is present in extravascular tissues but not in plasma. Vd = dose / plasma concentration It can be expressed as liters or indexed to body mass in L/kg.
82
What does a drug with high Vd mean?
Leave the plasma and enter the extravascular compartments of the body High Vd -> More distribution to other tissue A higher dose of a drug is required to achieve a given plasma concentration.
83
What does a drug with low Vd mean?
Remains in the plasma (Low Vd -> Less distribution to other tissue) A lower dose of a drug is required to achieve a given plasma concentration.
84
What are the effect of Vd on drug half life?
A drug with a high Vd Most of drugs in the extra-plasma space ->Not readily available for elimination. So it takes longer time to be eliminated -> Half-life is longer
85
What is Cmax?
: The highest drug concentration in the body
86
What is tmax?
: Time at which the highest concentration occurs
87
What is T1/2 (Half Life) ?
T1/2 (Half Life) : Time taken to remove the half of the current concentration of the drug from the body
88
What is AUC: (Area Under the Curve)?
Represents the total exposure to a drug that the body receives. AUC shows how high the concentration [C] of the drug gets, as well as how quickly it is excreted
89
Between lipophilic drugs and waterphili drugs, which gets excreted faster via kidney?
waterphilic
90
Elimination can happen which 2 ways?
By excretion of an unmetabolized drug in its intact form by kidney or By metabolic biotransformation followed by excretion
91
What organs take part in excretion?
By several organs: Kidneys, GI tract (feces and biles), lungs, skin, mammary glands, sweat glands, salivary glands.
92
What are the steps to renal excretion?
Glomerular filtration Proximal tubular secretion - water soluble medication gets excreted with energy, non polarized, lipid soluble drugs goes via passive diffusion Distal tubular reabsorption - most of the nonpolizated will get back into capillary nephron At the end, excretion have the ionized, lipid insoluble drug into urine (water soluable)
93
What is Total Clearance (CL total )?
Represents the capacity for drug elimination by various organs The volume of plasma cleared of a medication per unit of time (ml/min or L/hr) defined as the volume of plasma cleared of a drug over a specified time period Drug’s half life is used as a measure of drug clearance Elimination kinetics play an essential role in drug clearance.
94
What is First - order kinetics (linear kinetics) (exponential decrease)
Most drugs gets eliminated through this kinetics A constant proportion of drug (%) is eliminated per unit of time Absolute amount of drug eliminated is different Rate of elimination is directly proportional to the concentration of drug As the concentration of the drug drops, the rate of elimination of the drug will drop
95
What is Zero-order (Non-linear elimination ) kinetics ?
Rate of drug elimination is independent of the concentration of the drugs Absolute amount of drugs eliminated is the same per unit of time but not a proportion of drug. Phenytoin or ethanol or warfarin, aspirin
96
Half-life ( T½)
Time required for the drug concentration to be reduced by 50 % Useful for estimating excretion rates and steady-state concentrations for any specific drug Clinically relevant when determining the most efficient yet safest dosing schedule to achieve an optimal therapeutic effect The clinical significance of half-life tends to arise in situations involving drug toxicity. Renal impairment Hepatic impairment
97
What is a Steady-state concentration (Css)
A dynamic equilibrium in which drug concentrations consistently stay within therapeutic limits for long periods. Rate of elimination = rate of administration Occurs when the amount of a drug being absorbed is the same amount that's being cleared from the body when the drug is given continuously or repeatedly. Reaching a steady-state concentration is generally necessary for efficacy of drugs
98
What is a drug's half life used to measure?
Drug’s half life is used as a measure of drug clearance